Open AccessVP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication
Author(s) -
Jun Yi,
Weidong Gong,
Ling Wang,
Rui Ling,
Jianghao Chen,
JiSup Yun
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i41.6429
Subject(s) - hepatitis b virus , mutant , hbsag , microbiology and biotechnology , transfection , viral replication , biology , virology , plasmid , fusion protein , mtt assay , cell culture , virus , dna , gene , biochemistry , recombinant dna , genetics
To investigate the inhibitory effect of VP22 fusion protein-based dominant negative (DN) mutant on Hepatitis Bvrus (HBV) replication.